Evaluation of the Safety and Effectiveness of the CereVasc eShunt System in the Treatment of Normal Pressure Hydrocephalus

Brief description of study

This study is evaluating the eShunt System for the treatment of patients with normal pressure hydrocephalus. The treatment is intended to reduce disability due to symptoms including one or more of gait disturbance, cognitive dysfunction and urinary incontinence.

Clinical Study Identifier: s22-00878
ClinicalTrials.gov Identifier: NCT05232838
Principal Investigator: Howard Antony Riina.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.